206 related articles for article (PubMed ID: 27888873)
1. Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?
Sujobert P; Salles G; Bachy E
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1163-1177. PubMed ID: 27888873
[TBL] [Abstract][Full Text] [Related]
2. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
3. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
Hill BT; Sweetenham J
Leuk Lymphoma; 2012 May; 53(5):763-9. PubMed ID: 21992676
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma: the old and the new.
Cabanillas F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the pathogenesis of molecular subtypes of diffuse large B-cell lymphoma and their clinical implications.
Frontzek F; Lenz G
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1059-1067. PubMed ID: 31645159
[No Abstract] [Full Text] [Related]
8. Molecular pathogenesis in non-Hodgkin lymphoma: implications for therapy.
Vose JM
Transfus Apher Sci; 2013 Oct; 49(2):155-6. PubMed ID: 24051218
[TBL] [Abstract][Full Text] [Related]
9. Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
Bobée V; Ruminy P; Marchand V; Viailly PJ; Abdel Sater A; Veresezan L; Drieux F; Bérard C; Bohers E; Mareschal S; Dubois S; Jais JP; Leroy K; Figeac M; Picquenot JM; Molina TJ; Salles G; Haioun C; Tilly H; Jardin F
J Mol Diagn; 2017 Nov; 19(6):892-904. PubMed ID: 29054399
[TBL] [Abstract][Full Text] [Related]
10. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.
Camicia R; Winkler HC; Hassa PO
Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227
[TBL] [Abstract][Full Text] [Related]
11. Appropriate management of molecular subtypes of diffuse large B-cell lymphoma.
Dunleavy K; Wilson WH
Oncology (Williston Park); 2014 Apr; 28(4):326-34. PubMed ID: 24839807
[TBL] [Abstract][Full Text] [Related]
12. Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System.
Veldman-Jones MH; Lai Z; Wappett M; Harbron CG; Barrett JC; Harrington EA; Thress KS
Clin Cancer Res; 2015 May; 21(10):2367-78. PubMed ID: 25301847
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling in diffuse large B-cell lymphoma.
Morgensztern D; Martin MG; Lossos IS
Leuk Lymphoma; 2007 Apr; 48(4):669-82. PubMed ID: 17454624
[TBL] [Abstract][Full Text] [Related]
14. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
Michaelsen TY; Richter J; Brøndum RF; Klapper W; Johnsen HE; Albertsen M; Dybkær K; Bøgsted M
Blood Adv; 2018 Jul; 2(13):1542-1546. PubMed ID: 29967255
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.
Chao CN; Huang YL; Lin MC; Fang CY; Shen CH; Chen PL; Wang M; Chang D; Tseng CE
J Transl Med; 2015 Jan; 13():29. PubMed ID: 25623859
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.
Tirado CA; Chen W; García R; Kohlman KA; Rao N
J Hematol Oncol; 2012 Sep; 5():54. PubMed ID: 22967872
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
20. High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified.
Hwang HS; Park CS; Yoon DH; Suh C; Huh J
Am J Surg Pathol; 2014 Aug; 38(8):1046-57. PubMed ID: 24705314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
